Page last updated: 2024-12-11

24-ethyl-4-cholesten-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

stigmast-4-en-3-one: from the bark of Anacardium occidentale (cashew); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5484202
CHEMBL ID66926
CHEBI ID68105
SCHEMBL ID873360
MeSH IDM0149626

Synonyms (24)

Synonym
4-stigmasten-3-one
stigmast-4-en-3-one
24(r)-stigmast-7,22 (e)-dien-3a-ol
(8s,9s,10r,13r,14s,17r)-17-[(1r,4r)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
beta-sitostenone
CHEMBL66926
chebi:68105 ,
(8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
nsc 49082
24-eceo
stigmast-4-en-3-one, (24xi)-
67392-96-5
24-ethyl-4-cholesten-3-one
4-stigmasta-ene-3-one
SCHEMBL873360
3-oxo-24-ethyl-cholest-4-ene
.delta.4-sitosterol-3-one
(8s,9s,10r,13r,14s,17r)-17-((2r,5r)-5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3(2h)-one
Q27136596
DTXSID50862519
4-sitosterol-3-one; -rosasterol oxide; -sitost-4-en-3-one; -sitostenone
CS-0016639
HY-N1238
FS-10107
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
steroidAny of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene which is a triterpene.
C29-steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
sitosterol degradation to androstenedione033

Bioassays (18)

Assay IDTitleYearJournalArticle
AID1386848Antiproliferative activity against mouse L5178Y cells after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1386852Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1607865Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production2019European journal of medicinal chemistry, Oct-01, Volume: 179Human disorders associated with inflammation and the evolving role of natural products to overcome.
AID1386850Cytotoxicity against human COLO320 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID7636Compound was evaluated for its potency in CDF1 mice and the serum triglyceride levels were determined1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID113559Evaluated for potency in CDF1 mice and the ability of it to decrease feed consumption was determined1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID1386859Modulation of ABCB1 (unknown origin) expressed in human COLO320 cells co-expressing LRP assessed as fluorescence activity ratio at 20 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 0.79 No_2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1386851Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID226241Feed efficiency was calculated by dividing body weight gain by feed consumption in mouse1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID1386858Modulation of ABCB1 (unknown origin) expressed in human COLO320 cells co-expressing LRP assessed as fluorescence activity ratio at 2 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 0.79 No_u2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID110288Evaluated for potency in CDF1 mice and the inhibition of body weight gain was determined1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID1386849Antiproliferative activity against mouse L5178Y cells harboring human ABCB1 after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID7634Compound was evaluated for its potency in CDF1 mice and the serum cholesterol levels were determined1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID1386855Modulation of human ABCB1 expressed in mouse L5178Y cells assessed as fluorescence activity ratio at 2 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 1.01 No_unit)2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1386853Cytotoxicity against human MRC5 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID7635Compound was evaluated for its potency in CDF1 mice and the serum metabolite levels were determined1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID108710Compound was evaluated for its potency in CDF1 mice and the abdominal fat weight was determined.1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
AID1386856Modulation of human ABCB1 expressed in mouse L5178Y cells assessed as fluorescence activity ratio at 20 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 1.01 No_unit)2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.56)18.7374
1990's1 (5.56)18.2507
2000's4 (22.22)29.6817
2010's10 (55.56)24.3611
2020's2 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.14 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]